We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+23.92%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$238M
AUM Growth
+$30.8M
Cap. Flow
+$7.19M
Cap. Flow %
3.03%
Top 10 Hldgs %
44.18%
Holding
90
New
31
Increased
11
Reduced
13
Closed
28

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$17.6M
2
AGN
Allergan plc
AGN
+$7.13M
3
RARE icon
Ultragenyx Pharmaceutical
RARE
+$6.94M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$6.03M
5
ESRX
Express Scripts Holding Company
ESRX
+$5.03M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$13.6M
2
MDT icon
Medtronic
MDT
+$9.03M
3
RCPT
RECEPTOS INC COM STK (DE)
RCPT
+$6.13M
4
VTRS icon
Viatris
VTRS
+$5.64M
5
AMGN icon
Amgen
AMGN
+$5.58M

Sector Composition

Rank Sector Weight
1 Healthcare 81.93%
2 Real Estate 0.91%
3 Technology 0.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTRS icon
76
Viatris
VTRS
$18.5B
– –
-100,000
Closed -$5.64M
XBI icon
77
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.5B
– –
-75,000
Closed -$4.66M
XLV icon
78
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$44B
– –
-125,000
Closed -$8.55M
CMRX
79
DELISTED
Chimerix, Inc.
CMRX
– –
-75,000
Closed -$3.02M
RAD
80
DELISTED
Rite Aid Corporation
RAD
– –
-10,000
Closed -$1.5M
XLRN
81
CALL
DELISTED
Acceleron Pharma
XLRN
– –
-25,000
Closed -$974K
ACHN
82
CALL
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-125,000
Closed -$1.53M
ACHN
83
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-75,000
Closed -$919K
KERX
84
CALL
DELISTED
Keryx Biopharmaceuticals Inc
KERX
– –
-30,000
Closed -$425K
IPXL
85
PUT
DELISTED
Impax Laboratories, Inc.
IPXL
– –
-100,000
Closed -$3.17M
ELOS
86
DELISTED
Syneron Medical Ltd
ELOS
– –
-175,000
Closed -$1.63M
RCPT
87
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
– –
-50,000
Closed -$6.13M
VOLC
88
DELISTED
VOLCANO CORPORATION COM STK
VOLC
– –
-200,000
Closed -$3.58M
AVNR
89
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
– –
-200,000
Closed -$3.39M
SHPG
90
DELISTED
Shire pic
SHPG
– –
-20,000
Closed -$4.25M
1 2 3
4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q1 2015 Portfolio in Review

As of Q1 2015, Iguana Healthcare Management held 90 positions worth $238M, up 15% from $207M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Iguana Healthcare Management deployed $7.19M of net new capital in Q1 2015, opening 31 new positions and adding to 11 existing holdings. Its largest new stake was Allergan plc: 25,000 shares worth $7.44M.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, up from 71% a quarter earlier, followed by Real Estate and Technology.

On the sell side, the largest reduction was Gilead Sciences, an estimated $2.54M trimmed.

  • Iguana Healthcare Management's largest Q1 2015 buy was Allergan plc: 25,000 shares worth $7.44M.
  • Iguana Healthcare Management added most to Pfizer in Q1 2015, an estimated $17.6M increase.
  • Iguana Healthcare Management's biggest Q1 2015 reduction was Gilead Sciences, cutting an estimated $2.54M.
  • Iguana Healthcare Management fully exited Biogen in Q1 2015, selling an estimated $13.6M.
  • Iguana Healthcare Management's ten largest holdings make up 44% of its $238M portfolio in Q1 2015.
  • Iguana Healthcare Management opened 31 new positions and closed 28 in Q1 2015.
  • Iguana Healthcare Management's portfolio value rose 15% quarter-over-quarter to $238M.

Based on Iguana Healthcare Management's 13F filing for Q1 2015, filed 18 May 2015.